Alain Rivard

Alain Rivard is a Professor in the Department of Medicine at the University of Montreal's Faculty of Medicine. He is affiliated with the CRCHUM (Centre de recherche du Centre hospitalier de l’Université de Montréal). His research focuses on clinical phenotypes influencing atherosclerosis and angiogenesis, with expertise in molecular biology, cardiovascular disease mechanisms, and ischemia-induced neovascularization. His work integrates fundamental research methodologies to address pathologies such as atherosclerosis, restenosis, coronary diseases, and aging-related vascular issues.

Key research projects include investigating extracellular vesicles' role in enhancing neovascularization in peripheral artery disease (2020-2027, IRSC-funded), targeting soluble guanylate cyclase to improve neovascularization (2017-2022, FMCC-funded), and exploring microRNA modulation of ischemia-induced neovascularization (2012-2019, IRSC-funded). Earlier projects examined NOX2/SOD1's role in endothelial repair (2011-2014, Quebec Heart and Lung Institute-funded).

Dr. Rivard has supervised multiple graduate students, including studies on neonatal hyperoxia's effects on adult neovascularization, renin/microRNA mechanisms in ischemia, and the impact of cardiovascular risk factors on post-ischemic angiogenesis. His research has consistently addressed translational aspects of vascular repair and therapeutic interventions for cardiovascular diseases.

He holds grants totaling over CAD 5 million from prestigious agencies, demonstrating sustained research excellence. His work bridges basic science and clinical applications, with a focus on improving therapeutic strategies for ischemic and cardiovascular conditions.